Lundbeck

Lundbeck is a leading global pharmaceutical company specializing exclusively in neuroscience. Founded in 1915 in Copenhagen by Hans Lundbeck, we have over 100 years of experience in the research, development, manufacturing, and commercialization of innovative pharmaceuticals targeting brain diseases. Our mission focuses on advancing brain health and transforming the lives of those affected by mental health disorders and neurological diseases.

With more than 5,600 employees across over 50 countries, Lundbeck is committed to addressing significant unmet needs in brain health. Our portfolio includes a range of established therapies for conditions such as depression, schizophrenia, bipolar disorder, and Alzheimer's disease. We operate research facilities in both Denmark and the United States, which enable us to stay at the forefront of neuroscience innovation. Our collaboration with healthcare professionals and patient advocacy groups ensures that we understand and respond to the challenges faced by patients globally. At Lundbeck, we believe in a world where mental health is recognized as crucial to overall health, and we are dedicated to fighting stigma and improving access to effective treatments for those in need.